Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research

The summary for the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research: The National Institute of Allergy and Infectious Diseases (NIAID) is expanding the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) program. The overall goal of the RCE Program is development and maintenance of a strong infrastructure and multifaceted research and development activities that will provide the scientific information and translational research capacity that will lead to the next generation of therapeutics, vaccines and diagnostics against the NIAID Category A-C Agents (http://www.niaid.nih.gov/biodefense/bandc_priority.htm). To realize this goal, the Centers will be provided with support to: 1) develop and conduct programs of investigator-directed research; 2) train researchers and other personnel for biodefense and emerging infectious diseases research activities; 3) develop and maintain comprehensive core facilities that support the research and training activities of the RCE and make these available to qualified investigators from academia, biotechnology companies, the pharmaceutical industry, and other appropriate entities in the geographic region; 4) develop translational research capacity for testing and validating vaccine, therapeutic and diagnostic concepts for biodefense and emerging infectious diseases; and 5) be prepared and available to provide facilities and scientific support to first-line responders in the event of a national biodefense emergency. This Request for Applications (RFA) invites research institutions and groups of investigators to form consortia and develop new applications for research programs which address the fundamental research and development questions expected to yield the information required to counter the threat of bioterrorism. Diverse research and development approaches are encouraged as long as they include the following essential features: a research focus on NIAID Category A-C agents including the incorporation of a translational component with the long term goal of developing products for human use. Additionally, consortia must document: institutional commitment; organizational capabilities; ability to develop and expand facilities; plans for training investigators and other participants in the national biodefense effort; and interdisciplinary coordination and collaboration, particularly linkages to federal, state, and local agencies as well as the private sector. Consortia must have a lead team of individuals responsible for the overall management and direction of the RCE. A group of Center member researchers, with expertise in biodefense and emerging infectious diseases, is required to lead the research thrust which underlies all activities of the RCE. Centers should emphasize the use of cutting-edge approaches and technologies. To ensure that the RCE program contributes maximally and effectively to the NIAID biodefense and emerging infectious diseases effort, the overall direction and scope of activities of the Program and its participant Center sites will be centrally coordinated and monitored by the NIAID Biodefense Network. The Network, which is operated through the RCE Program Office at NIAID, includes the RCE Program Staff, RCE Principal Investigators, and the Principal Investigators of the National Biocontainment and Regional Biocontainment Laboratories (http://www.niaid.nih.gov/newsroom/releases/nblscorrect21.htm) To achieve nationwide distribution of the RCEs, the NIAID will use the 10 established DHHS regions: REGION I: CT, ME, MA, NH, RI, VT REGION II: NJ, NY, PR, VI REGION III: DE, D.C., MD, PA, VA, WV REGION IV: KY, MS NC, TN, AL, FL, GA, SC REGION V: IL, IN, MI, MN, OH, WI REGION VI: AR, LA, NM, OK, TX REGION VII: IA, KS, MO, NE REGION VIII: CO, MT, ND, SD, UT, WY REGION IX: AZ, CA, HI, NV, and the six U.S. Associated Pacific jurisdictions REGION X: AK, ID, OR, WA It is the long-range goal of this program, contingent upon the availability of funds, to establish at least one RCE within each region. NIAID encourages applications from all regions of the country, particularly those that do not have existing RCEs. Applicants from regions with currently funded RCEs should address the additional value of having another Center in the region and how the proposed activities would relate to those ongoing at the established RCE. Although preference is to establish RCEs in those regions that currently do not have one, it is only one of several factors that will be considered in making funding decisions.
Federal Grant Title: Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-04-018
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.85593.856
CFDA Descriptions: Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research
Current Application Deadline: No deadline provided
Original Application Deadline: Sep 09, 2004
Posted Date: Apr 05, 2004
Creation Date: Apr 05, 2004
Archive Date: Oct 14, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com